donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
02633 Jacobson Pharma Corporation
0.6700.0000.00%
YOY
Do not show
Hide blank lines
(Q6)2021/09/30(FY)2021/03/31(Q6)2020/09/30(FY)2020/03/31
Turnover
7.91% 750.41M -7.99% 1.45B -8.16% 695.43M 6.31% 1.57B
Operating income
7.91% 750.41M -7.99% 1.45B -8.16% 695.43M 6.31% 1.57B
Cost of sales
-11.28% -477.57M -0.38% -884.83M -5.56% -429.17M -9.71% -881.48M
Operating expenses
-11.28% -477.57M -0.38% -884.83M -5.56% -429.17M -9.71% -881.48M
Gross profit
2.47% 272.84M -18.68% 561.08M -24.07% 266.26M 2.27% 689.98M
Selling expenses
3.42% -88.59M 9.15% -177.41M 0.51% -91.73M -15.64% -195.29M
Administrative expenses
4.83% -93.98M -11.43% -230.17M -1.31% -98.75M -19.92% -206.57M
Special items of operating profit
-62.56% 26.6M 241.44% 102.74M 195.27% 71.05M -18.81% 30.09M
Operating profit
-20.4% 116.87M -19.48% 256.24M -20.65% 146.83M -14.13% 318.22M
Financing cost
18.06% -12.87M 45.55% -30.14M 48.38% -15.7M 16.37% -55.36M
Share of profits of associates
-17.32% -1.82M -284.45% -3.68M -152.89% -1.55M -57.77% 1.99M
Share of profit from joint venture company
83.85% -285K -35.6% -1.85M -- -1.77M -- -1.37M
Earning before tax
-20.27% 101.91M -16.29% 220.57M -18.88% 127.81M -14.76% 263.49M
Tax
-23.98% -19.05M 25.55% -34.26M 44.71% -15.36M 17.11% -46.03M
After-tax profit from continuing operations
-26.31% 82.86M -14.33% 186.31M -13.35% 112.45M -14.24% 217.46M
After-tax profit from non-continuing business
-- -- -99.82% 3K -99.86% 3K -67.71% 1.65M
Earning after tax
-26.32% 82.86M -14.97% 186.31M -14.73% 112.45M -15.3% 219.11M
Minority profit
-71.63% 2.82M 262.24% 12.6M 113.26% 9.94M -57.16% 3.48M
Shareholders should account for profits from continuing business
-21.92% 80.04M -19.01% 173.71M -18.48% 102.51M -13.09% 214.49M
Shareholders should account for profits from non-continuing business
-- -- -99.74% 3K -99.8% 3K -69.81% 1.14M
Profit attributable to shareholders
-21.92% 80.04M -19.44% 173.71M -19.42% 102.51M -13.94% 215.63M
Basic earnings per share
-21.87% 0.0418 -16.56% 0.0907 -15.35% 0.0535 -16.26% 0.1087
Diluted earnings per share
-21.87% 0.0418 -16.56% 0.0907 -15.35% 0.0535 -16.26% 0.1087
Currency Unit
HKDHKDHKDHKD
Accounting Standards
HKASHKASHKASHKAS
Audit Opinions
--Unqualified Opinion--Unqualified Opinion
Auditor
--KPMG accounting firm--KPMG accounting firm

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Jacobs Research Pharmaceutical Co., Ltd. is a Hong Kong company engaged in the manufacture and trading of generics and proprietary Chinese medicines. The company operates through two major divisions. The generic drugs Division develops, produces and distributes generic drugs for therapeutic purposes. At present, the branch business is mainly carried out in Hong Kong. Proprietary Chinese Medicine Division develops, manufactures and distributes traditional Chinese medicine. At present, the branch business is mainly carried out in Hong Kong.
CEO: Guangye Cen
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...